TY - JOUR
T1 - Evolution of a Transplant Surgery Advanced Practice Provider Practice Model in the Care of High-Acuity Liver Transplant Recipients
T2 - A Single-Center Experience
AU - Mahaffey, Jennifer J.
AU - Selim, Motaz A.
AU - Kristbaum, Kelly A.
AU - Mayer, Jenessa
AU - Martin, Alicia
AU - Durazo, Francisco A.
AU - Hong, Johnny C.
N1 - Funding Information:
Supported by the American Society of Transplant Surgeons Advanced Transplant Provider Research Grant to Jennifer J. Mahaffey, PA-C (grant no. FP00019698).
Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/12
Y1 - 2022/12
N2 - Background: The role of advanced practice providers (APPs) in an academic transplant surgical acute care setting remains to be defined. We sought to evaluate the impact of a transplant surgeon–APP (TSAPP) practice model on patient access and outcomes in the care of critically ill patients with end-stage liver disease (ESLD) in an academic transplant center. Methods: A retrospective analysis evaluated the effect of practice model evolution over an 11-year period on hospital access of patients with ESLD to an academic liver transplantation center and survival outcomes. We compared 3 practice models: era 1 (transplant surgeon–general surgery resident; January 2009 to Sept 2012): vs era 2 ( transition transplant surgeon–general surgery resident to TSAPP; October 2012 to December 2016): vs era 3 (TSAPP; January 2017 to December 2020). Results: Patient access to hospitalization and inpatient service census increased significantly over time with TSAPP model (P < .01). At the time of liver transplant, the median Model for End-Stage Liver Disease scores for era 1 (25), era 2 (33), and era 3 (34), P < .01, and patient requirement for intensive care unit for era 1 (7.1%), era 2 (44.8%), and era 3 (56.4%), P < .01, have increased. The overall 1-year patient survival rates remained comparable across all eras: era 1 (93.88%), era 2 (93.11%), and era 3 (94.06%), P = .77 Conclusions: The APPs play an integral role in clinical transplantation practice. The integration of APPs into the transplant surgical workforce increased access of high-acuity patients with ESLD to the transplantation center. In addition, it provided excellent patient and graft survival outcomes after liver transplant.
AB - Background: The role of advanced practice providers (APPs) in an academic transplant surgical acute care setting remains to be defined. We sought to evaluate the impact of a transplant surgeon–APP (TSAPP) practice model on patient access and outcomes in the care of critically ill patients with end-stage liver disease (ESLD) in an academic transplant center. Methods: A retrospective analysis evaluated the effect of practice model evolution over an 11-year period on hospital access of patients with ESLD to an academic liver transplantation center and survival outcomes. We compared 3 practice models: era 1 (transplant surgeon–general surgery resident; January 2009 to Sept 2012): vs era 2 ( transition transplant surgeon–general surgery resident to TSAPP; October 2012 to December 2016): vs era 3 (TSAPP; January 2017 to December 2020). Results: Patient access to hospitalization and inpatient service census increased significantly over time with TSAPP model (P < .01). At the time of liver transplant, the median Model for End-Stage Liver Disease scores for era 1 (25), era 2 (33), and era 3 (34), P < .01, and patient requirement for intensive care unit for era 1 (7.1%), era 2 (44.8%), and era 3 (56.4%), P < .01, have increased. The overall 1-year patient survival rates remained comparable across all eras: era 1 (93.88%), era 2 (93.11%), and era 3 (94.06%), P = .77 Conclusions: The APPs play an integral role in clinical transplantation practice. The integration of APPs into the transplant surgical workforce increased access of high-acuity patients with ESLD to the transplantation center. In addition, it provided excellent patient and graft survival outcomes after liver transplant.
UR - http://www.scopus.com/inward/record.url?scp=85142374384&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85142374384&partnerID=8YFLogxK
U2 - 10.1016/j.transproceed.2022.09.030
DO - 10.1016/j.transproceed.2022.09.030
M3 - Article
C2 - 36411094
AN - SCOPUS:85142374384
SN - 0041-1345
VL - 54
SP - 2621
EP - 2626
JO - Transplantation proceedings
JF - Transplantation proceedings
IS - 10
ER -